Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Pharmacopeia logo — Innovating to meet critical health challenges with advanced...

Pharmacopeia

Innovating to meet critical health challenges with advanced therapeutic discoveries and developments.

Founded 1993 Series Unknown Total: $7.63M Biopharma, Biotechnology +1

General Information

Company Name Pharmacopeia
Founded Year 1993
Founders / Decision Makers
Maria L. Webb — Vice President of Preclinical Research
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when Pharmacopeia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pharmacopeia

The biopharmaceutical company Pharmacopeia is focused on addressing critical medical needs through therapeutic discoveries and developments. It has a diverse internal program portfolio, including PS433540, a dual-acting angiotensin and endothelin receptor antagonist, and PS178990, a muscle-selective SARM agonist, both in clinical development stages. The company’s pipeline also includes PS031291, a preclinical product targeting multiple myeloma and inflammatory conditions, and JAK3 inhibitors for dermatologic and ocular diseases. Pharmacopeia has strategically aligned with major pharmaceutical entities such as Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, and Wyeth Pharmaceuticals. Established in 1993 as Pharmacopeia Drug Discovery, Inc., and later renamed in 2007, the company operates as a subsidiary of Ligand Pharmaceuticals Inc. in Cranbury, New Jersey. In 27 July 2005, the company secured a $7.63M Venture Round investment from Senvest Capital, Highbridge Capital Management, Iroquois Capital, ClearArc Capital, Nite Capital Management, Clarion Capital Partners, Carpe Diem Capital Management, Downsview Capital, and Balyasny Asset Management.

Taxonomy: biopharmaceutical, therapeutics, clinical development, cardiovascular diseases, renal diseases, muscle-selective SARM agonist, preclinical development, multiple myeloma, inflammatory conditions, JAK3 inhibitors, strategic alliances, pharmaceutical company, drug discovery, Ligand Pharmaceuticals, New Jersey

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $7.63M 9
Senvest Capital Highbridge Capital Management Iroquois Capital ClearArc Capital
Nite Capital Management, Clarion Capital Partners +3 		27 Jul 2005

Pharmacopeia Alternatives & Competitors

Pharmacopeia vs
Anthera Pharmaceuticals
Anthera Pharmaceuticals

Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health

Post Ipo Equity
Biotechnology, Health Care
Pharmacopeia vs
EPIX Pharmaceuticals
EPIX Pharmaceuticals

Pioneering tomorrow's treatments for central nervous system and lung diseases with proprietary drug...

28 employees
Biotechnology, Health and Wellness
Pharmacopeia vs
Idenix Pharmaceuticals
Idenix Pharmaceuticals

Pioneering advancements in antiviral therapies, focused on combating hepatitis and HIV, with a stron...

Post Ipo Equity
Biotechnology, Health Care

FAQ About Pharmacopeia

Innovating to meet critical health challenges with advanced therapeutic discoveries and developments.
Pharmacopeia was founded in 1993.
Pharmacopeia operates in the following industries: Biopharma, Biotechnology, Pharmaceutical.
Pharmacopeia has completed 1 funding round, raising a total of $7.63M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Pharmacopeia include Anthera Pharmaceuticals, EPIX Pharmaceuticals, Idenix Pharmaceuticals, ADARx Pharmaceuticals Inc., Arriva Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharmacopeia and Anthera Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pharmacopeia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy